SpaceX~$1TSpaceX~$1T
Insider Buying
Subscribe
All stock lists
BBNX

Beta Bionics, Inc. (NASDAQ:BBNX)

US · Delayed Price · Currency is USD
Healthcare · Medical - Devices
$13.36+$0.04 (+0.30%)
 
Market cap
$601M
Insider Score
Health Score
Analyst consensus
Listed since
Jan 30, 2025
Market Cap$601.06M-57.5%
Revenue (ttm)$127.27M+43.7%
Net Income-$83.12M-6.8%
EPS-$1.87-3.9%
Shares Out44.99M
PE Ration/a
Forward PEn/a
Dividendn/a
Ex-Dividend Daten/a
Volume960,302
Open$13.03
Previous Close$13.32
Day's Range$13.03 - $13.85
52-Week Range$8.80 - $32.71
Beta3.43
AnalystsBuy
Price Target$24.09(+80.31%)
Earnings DateFeb 16, 2027

About BBNX

Beta Bionics, Inc. is a commercial-stage medical technology company dedicated to inventing, developing, and bringing to market solutions that improve the health and quality of life for individuals with diabetes who depend on insulin. The company's flagship product, the iLet Bionic Pancreas, is an automated insulin delivery system currently available for treating type 1 diabetes in adults and children aged six and older. In addition to its existing offering, Beta Bionics is actively developing several new innovations: a Patch Pump, designed as a tubeless insulin pump that adheres directly to the skin; the Bihormonal iLet, which integrates automated delivery of both insulin and glucagon; and an iLet system specifically adapted for individuals with insulin-dependent type 2 diabetes. To support its product pipeline, the company has forged strategic alliances, including a collaboration and licensing agreement with Xeris Pharmaceuticals, Inc. to develop and commercialize a glucagon formulation compatible with pumps. It also holds a development and commercialization agreement with Abbott Diabetes Care Inc. for an automated insulin delivery system. Established in 2015, Beta Bionics is headquartered in Irvine, California.

Address
11 Hughes, Irvine, CA, 92618, US
Market Cap
601 million
Employees
422
Industrial Classification
Medical - Devices

What Are Insiders Doing?

Open-market buy / sell balanceNet Selling
Sold
$3.38M
Bought
$0

View the trades behind this meter — each links to its SEC Form 4 →

Open-market Form 4 purchases (code P) vs sales (code S) on file for this company. Grants, option exercises and tax withholdings are excluded. Informational only.

Analyst consensus

Moderate Buy
3 Buy3 Hold0 SellAvg target $25.38 (+90.0%)

6 firms rating BBNX in the last 3 months, one vote each. Issuer-paid research is not counted.

Financial Health Score
Fair
From BBNX’s reported statements · Q3 2026 (trailing 12 months)

Next catalysts

1 Day
+0.30%
5 Days
-17.63%
1 Month
-30.92%
6 Months
+13.03%
1 Year
-57.45%

$BBNX stock is featured in our Insider Score Rankings, and Insider Trades datasets.

→ All Stock Lists

Recently reported changes in BBNX holdings by institutional investors

Scanning latest 13F filings…

Latest 0 13F filings · Source: SEC EDGAR

View all institutional owners →

Insider Trading

Quarterly net insider trading by BBNX's directors and management

Net Shares Purchased by Insiders−200k−100k02025Q42026Q12026Q22026Q32026Q4

Source: SEC EDGAR (Form 4)

Corporate Lobbying

BBNX Estimated quarterly lobbying spending

Source: U.S. Senate LDA

BBNX Revenue by Segment

$35.51MTotal
DME Channel$21.90M61.67%
PBP Channel$13.61M38.33%

As of: Q3 2026 (Sep 30, 2026) · Source: SEC EDGAR (10-Q)

U.S. Patents

New BBNX patent grants

Loading patent grants…

Source: USPTO Open Data Portal

Government Contracts

Estimated quarterly amount awarded to BBNX from public contracts

Source: USAspending.gov

Top ETF Holders

ETFs with the largest estimated holdings in BBNX

VTIVanguard Morningstar Total Stock Market ETF$22.84M
IWMiShares Russell 2000 ETF$14.44M
VXFVanguard Extended Market ETF$8.61M
IWNiShares Russell 2000 Value ETF$5.13M
TMSLT. Rowe Price Small-Mid Cap ETF$4.89M
VTWOVanguard Russell 2000 ETF$4.01M

Estimated from each fund’s disclosed top holdings × AUM

Bull Case vs Bear Case

AI-generated from BBNX’s recent data — informational, not investment advice

Generating analysis…

What’s Behind the Score

Insider Activity
48% of score
0
Analyst Ratings
32% of score
85
News & Sentiment
20% of score
72

News check: Product integration launch with Senseonics represents concrete commercial expansion, suggesting positive near-term revenue catalysts and market traction.

Recent Insider Activity

Buys
0
Sells
22
Buy Value
$0
Distinct Buyers
0

Insider Score Trend Over Time

+0.0 since Sep 4
0255075100Sep 4 — Insider Score 0.0Sep 5 — Insider Score 0.0Sep 6 — Insider Score 0.0Sep 7 — Insider Score 0.0Sep 8 — Insider Score 0.0Sep 9 — Insider Score 0.0Sep 10 — Insider Score 0.0Sep 11 — Insider Score 0.0Sep 12 — Insider Score 0.0Sep 13 — Insider Score 0.0Sep 14 — Insider Score 0.0Sep 15 — Insider Score 0.0Sep 16 — Insider Score 0.0Sep 17 — Insider Score 0.0Sep 18 — Insider Score 0.0Sep 19 — Insider Score 0.0Sep 20 — Insider Score 0.0Sep 21 — Insider Score 0.0Sep 22 — Insider Score 0.0Sep 23 — Insider Score 0.0Sep 24 — Insider Score 0.0Sep 25 — Insider Score 0.0Sep 26 — Insider Score 0.0Sep 27 — Insider Score 0.0Sep 28 — Insider Score 0.0Sep 29 — Insider Score 0.0Sep 30 — Insider Score 0.0Oct 1 — Insider Score 0.0Oct 2 — Insider Score 30.0Oct 3 — Insider Score 0.0Oct 4 — Insider Score 0.0Sep 4Sep 19Oct 4

Composite Insider Score (0–100) recomputed on each scoring run from live SEC Form 4 data.

Frequently Asked Questions

Disclaimer — Informational only — not investment advice. Insider transaction data is sourced from SEC Form 4 filings; market data from public feeds and may be delayed. The Insider Score is a proprietary score for research purposes and does not predict future performance. Always do your own research.

ETFs that hold this stock

XHEState Street SPDR S&P Health Care Equipment ETF1.44%
PTHInvesco Dorsey Wright Healthcare Momentum ETF0.73%
SGRWHarbor Active Small Cap Growth ETF (SGRW)0.40%
SNSRGlobal X - Internet of Things ETF0.40%
DWASInvesco Dorsey Wright SmallCap Momentum ETF0.30%
TNXTT. Rowe Price Innovation Leaders ETF0.24%
EKGFirst Trust Nasdaq Lux Digital Health Solutions ETF0.19%
TMSLT. Rowe Price Small-Mid Cap ETF0.17%
IHIiShares U.S. Medical Devices ETF0.10%
GINNGoldman Sachs Innovate Equity ETF0.06%
VTWVVanguard Russell 2000 Value ETF0.05%
IWNiShares Russell 2000 Value ETF0.05%

Weight is the stock’s share of each fund’s holdings.